These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9262227)

  • 1. Examination of telomere lengths in muscle tissue casts doubt on replicative aging as cause of progression in Duchenne muscular dystrophy.
    Oexle K; Zwirner A; Freudenberg K; Kohlschütter A; Speer A
    Pediatr Res; 1997 Aug; 42(2):226-31. PubMed ID: 9262227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cause of progression in Duchenne muscular dystrophy: impaired differentiation more probable than replicative aging.
    Oexle K; Kohlschütter A
    Neuropediatrics; 2001 Jun; 32(3):123-9. PubMed ID: 11521207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle regeneration and satellite cells in Fukuyama type congenital muscular dystrophy.
    Terasawa K
    Muscle Nerve; 1986 Jun; 9(5):465-70. PubMed ID: 3724791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erosion of telomeric 3'-overhangs in white blood cells of aged subjects with high frequency of very short telomeres.
    Mattarocci S; D'Ambrosio E; Tafaro L; Somma V; Zannino G; Marigliano V; Ascenzioni F; Cimino-Reale G
    Mech Ageing Dev; 2011; 132(1-2):27-32. PubMed ID: 21126532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere shortening in diaphragm and tibialis anterior muscles of aged mdx mice.
    Lund TC; Grange RW; Lowe DA
    Muscle Nerve; 2007 Sep; 36(3):387-90. PubMed ID: 17617801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere shortening with aging in the human pancreas.
    Ishii A; Nakamura K; Kishimoto H; Honma N; Aida J; Sawabe M; Arai T; Fujiwara M; Takeuchi F; Kato M; Oshimura M; Izumiyama N; Takubo K
    Exp Gerontol; 2006 Sep; 41(9):882-6. PubMed ID: 16860503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of type 2C muscle fibers in Duchenne muscular dystrophy.
    Nonaka I; Takagi A; Sugita H
    Muscle Nerve; 1981; 4(4):326-33. PubMed ID: 6166859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle fiber immaturity and inactivity reduce myonecrosis in Duchenne muscular dystrophy.
    Kimura S; Sugino S; Ohtani Y; Matsukura M; Nishino I; Ikezawa M; Sakata A; Kondo Y; Yoshioka K; Huard J; Nonaka I; Miike T
    Ann Neurol; 1998 Dec; 44(6):967-71. PubMed ID: 9851444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Becker and Duchenne muscular dystrophy: a comparative morphological study.
    Dennett X; Shield LK; Clingan LJ; Woolley DA
    Aust Paediatr J; 1988; 24 Suppl 1():15-20. PubMed ID: 3202735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
    Voit T; Stuettgen P; Cremer M; Goebel HH
    Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of human age according to telomere shortening in peripheral blood leukocytes of Tibetan.
    Ren F; Li C; Xi H; Wen Y; Huang K
    Am J Forensic Med Pathol; 2009 Sep; 30(3):252-5. PubMed ID: 19696580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Membrane changes in Duchenne/Becker muscular dystrophy: lectin binding and localization of dystrophin].
    Voit T; Patel K; Sewry CA; Strong PN; Dubowitz V; Dunn MJ
    Monatsschr Kinderheilkd; 1989 Jan; 137(1):20-7. PubMed ID: 2646527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
    J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy.
    Aguennouz M; Vita GL; Messina S; Cama A; Lanzano N; Ciranni A; Rodolico C; Di Giorgio RM; Vita G
    Neurobiol Aging; 2011 Dec; 32(12):2190-7. PubMed ID: 20137830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible neurogenic factor in muscular dystrophy: its similarity to denervation atrophy.
    Dastur DK; Razzak ZA
    J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):399-410. PubMed ID: 4714102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma levels of tissue inhibitors of metalloproteinase-1 and their overexpression in muscle in human and mouse muscular dystrophy.
    Sun G; Haginoya K; Chiba Y; Uematsu M; Hino-Fukuyo N; Tanaka S; Onuma A; Iinuma K; Tsuchiya S
    J Neurol Sci; 2010 Oct; 297(1-2):19-28. PubMed ID: 20655547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrasound imaging of muscles in Duchenne muscular dystrophy].
    Aizawa H; Kozima S; Takagi A
    Rinsho Shinkeigaku; 1989 Jan; 29(1):49-53. PubMed ID: 2663295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturational defect of regenerating muscle fibers in cases with Duchenne and congenital muscular dystrophies.
    Miike T
    Muscle Nerve; 1983 Oct; 6(8):545-52. PubMed ID: 6196637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Duchenne muscular dystrophy carrier presenting with mosaic X chromosome constitution and muscular symptoms--with analysis of the barr bodies in the muscle].
    Kinoshita M; Ikeda K; Yoshimura M; Saku A; Watanabe K
    Rinsho Shinkeigaku; 1990 Jun; 30(6):643-6. PubMed ID: 2225660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.